The evaluation of HER2 discordance and heterogeneity in pancreas adenocarcinoma

被引：0
|
作者：
Han, S. [1 ]
机构：
[1] Dong A Univ, Coll Med, Dept Pathol, Busan, South Korea
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-21-011
引用
收藏
页码：S216 / S216
页数：1
相关论文
共 50 条
  • [41] Brain metastasis in gastroesophageal adenocarcinoma and HER2 status
    Limon, Dror
    Gal, Omer
    Gordon, Noa
    Katz, Lior
    Perl, Gali
    Purim, Ofer
    Amit, Limor
    Stemmer, Salomon M.
    Kundel, Yulia
    Ben-Aharon, Irit
    Brenner, Baruch
    Siegal, Tali
    Yust-Katz, Shlomit
    JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (02) : 315 - 320
  • [42] HER2 STATUS IN 100 PATIENTS WITH GASTRIC ADENOCARCINOMA
    Beltran, B.
    Yabar, A.
    Riva, L.
    Castillo, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 243 - 243
  • [43] Pathologic Diagnostics of HER2 Positivity in Gastroesophageal Adenocarcinoma
    Koopman, Timco
    Louwen, Maarten
    Hage, Mariska
    Smits, Maria M.
    Imholz, Alex L. T.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (02) : 257 - 264
  • [44] Her2 expression in small bowel adenocarcinoma.
    Adediran, Samuel Gboyega
    Shah, Usman
    Gheith, Shereen
    Singh-Kahlon, Pal
    Fisher, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Breast cancer HER2 epigenetic intratumoral heterogeneity results from lack of HER2 protein translation
    Nitta, Hiroaki
    Horii, Rie
    Murillo, Adrian
    Portier, Bryce
    Akiyama, Futoshi
    CANCER RESEARCH, 2018, 78 (04)
  • [46] Tumour heterogeneity and discordance of ER, PR and HER2 receptors between primary and recurrent breast cancer: A systematic literature review
    Haria, Archana
    Mansfield, Kylie
    Hill, Jonathon
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 134 - 134
  • [47] Brain metastasis in gastroesophageal adenocarcinoma and HER2 status
    Dror Limon
    Omer Gal
    Noa Gordon
    Lior Katz
    Gali Perl
    Ofer Purim
    Limor Amit
    Salomon M. Stemmer
    Yulia Kundel
    Irit Ben-Aharon
    Baruch Brenner
    Tali Siegal
    Shlomit Yust-Katz
    Journal of Neuro-Oncology, 2018, 138 : 315 - 320
  • [48] HER2 or not HER2: That is the question
    Burstein, HJ
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3656 - 3659
  • [49] Impact of Genetic Heterogeneity on HER2 Status with Implementation of the 2013 ASCO/CAP HER2 Reporting Guidelines
    Estrada, Monica V.
    Kuba, Maria G.
    Rexer, Brent
    Manning, Suzanne
    Wheeler, Ferrin
    Yenamandra, Ashwini
    Sanders, Melinda E.
    LABORATORY INVESTIGATION, 2016, 96 : 41A - 41A
  • [50] Impact of Genetic Heterogeneity on HER2 Status with Implementation of the 2013 ASCO/CAP HER2 Reporting Guidelines
    Estrada, Monica V.
    Kuba, Maria G.
    Rexer, Brent
    Manning, Suzanne
    Wheeler, Ferrin
    Yenamandra, Ashwini
    Sanders, Melinda E.
    MODERN PATHOLOGY, 2016, 29 : 41A - 41A
12345